VET Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Vermilion Energy (VET) is not a good buy right now for a beginner long-term investor with $50,000-$100,000 who wants to act now rather than wait for a better entry. The stock lacks a strong bullish technical setup, has no recent news catalyst, and the proprietary signals are absent. Analyst sentiment is mixed-to-neutral with some target raises, but the consistent Sector Perform ratings suggest Wall Street is not broadly bullish. Overall, this looks like a hold rather than an immediate buy.
The current price is 11.23, slightly below the recent pivot level of 11.549 and just above support at 11.049. MACD histogram is negative at -0.0451, though the downside momentum is weakening. RSI_6 at 38.245 is neutral-to-weak, not oversold enough to imply a strong rebound signal. Moving averages are converging, which usually signals indecision rather than a confirmed uptrend. The stock trend model also points to weak near-term returns, with a 70% chance of slight declines over the next day, week, and month. Technically, VET is range-bound and not showing a strong buy setup.
["Analysts have recently raised price targets, including RBC Capital to C$24 and Scotiabank to C$19.", "ATB Capital upgraded the stock to Outperform with a C$24 target, which is a constructive signal.", "Options data is call-skewed, showing bullish trader sentiment.", "No recent negative news in the past week."]
["No news catalysts in the last week.", "Technical momentum is weak, with a negative MACD histogram and price below the pivot.", "The stock trend model suggests negative near-term performance.", "AI Stock Picker and SwingMax both show no signal today.", "Insiders and hedge funds are neutral, with no meaningful accumulation signal.", "Pre-market trading is weak at -1.87%."]
No latest quarter financial snapshot was available, so there is no confirmed recent earnings or revenue growth data to assess. Because the latest quarter season is not provided, financial momentum cannot be evaluated from the supplied data.
Analyst sentiment has improved recently: RBC Capital raised its target to C$24 from C$22 while keeping Sector Perform, Scotiabank raised its target to C$19 from C$16 and kept Sector Perform, and ATB Capital upgraded VET to Outperform with a C$24 target. The trend is constructive on price targets, but the recurring Sector Perform ratings show Wall Street remains cautious. Pros: higher targets and one upgrade to Outperform. Cons: the consensus still leans neutral rather than broadly bullish.
